Blog
RSS FeedPosted by Michael Wonder on 10 Nov 2023
Public Summary Documents – July 2023 PBAC meeting (round 2)
10 November 2023 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2023 ...
Posted by Michael Wonder on 09 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee (9 November 2023)
9 November 2023 - Two more documents are now available. ...
Posted by Michael Wonder on 06 Nov 2023
New treatment for women battling aggressive breast cancer
6 November 2023 - Women diagnosed with an aggressive form of breast cancer will have access to new treatment through the ...
Posted by Michael Wonder on 06 Nov 2023
New drug on PBS offers hope for women with aggressive breast cancer
5 November 2023 - A cutting-edge breast cancer drug has been added to the PBS for women with an especially ...
Posted by Michael Wonder on 04 Nov 2023
Hormone replacement therapy patch shortages are having a big impact on the women who need them
4 November 2023 - Women are being thrust back into the most severe stages of menopause amid long-running national shortages of ...
Posted by Michael Wonder on 04 Nov 2023
Updates to the HTA Policy and Methods Review Reference Committee (3 November 2023)
3 November 2023 - Further documents from the review are now available. ...
Posted by Michael Wonder on 02 Nov 2023
Launch of the Australian Cancer Plan
2 November 2023 - Learn about the new Australian Cancer Plan, which aims to improve prevention, screening, treatment and management of ...
Posted by Michael Wonder on 02 Nov 2023
National Immunisation Program – changes to shingles vaccination from today
1 November 2023 - From today, the shingles vaccine Shingrix has replaced Zostavax on the National Immunisation Program schedule for ...
Posted by Michael Wonder on 31 Oct 2023
Schedule of Pharmaceutical Benefits - 1 November 2023
1 November 2023 - The November 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Oct 2023
PBS listing expanded to include treatment resistant high frequency episodic migraine
31 October 2023 - From 1 November 2023, Australians with treatment resistant high frequency episodic migraine will have access to fremanezumab ...
Posted by Michael Wonder on 30 Oct 2023
Updates to the HTA Review Research and analysis papers collection: draft HTA expert paper published (30 October 2023)
30 October 2023 - The draft paper International Health Technology Market Approval, Funding and Assessment Pathways developed to support the ...
Posted by Michael Wonder on 30 Oct 2023
Expanded access to chronic heart failure treatment on the PBS
30 October 2023 - More Australians with chronic heart failure will have access to subsidised treatment under the PBS. ...
Posted by Michael Wonder on 30 Oct 2023
Updated agenda for November 2023 PBAC meeting (30 October 2023)
30 October 2023 - The agenda for this week's November 2023 meeting has been updated. ...
Posted by Michael Wonder on 30 Oct 2023
Expressions of interest to join the Pharmaceutical Benefits Remuneration Tribunal
30 October 2023 - The Department of Health is seeking expressions of interest to fill three vacancies on the Pharmaceutical ...
Posted by Michael Wonder on 29 Oct 2023
100,000 patients eligible for heart drug under PBS
28 October 2023 - Almost 100,000 patients are set to save hundreds of dollars per year as access to a ...